QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. USO
7. META
8. LMT
9. NVDA
10. TLT

Go back to QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
Qiagen NV (NYSE: QGEN) Delayed: 44.26 +1.36 (3.17%)
Previous Close $42.90    52 Week High $28.50 
Open $43.79    52 Week Low $19.94 
Day High $44.57    P/E 152.62 
Day Low $43.65    EPS $0.29 
Volume 1,175,823       

(NYSE: QIA) Delayed: 0.00 -10.35 (100%)
Previous Close $10.35    52 Week High $ 
Open $10.35    52 Week Low $ 
Day High $10.35    P/E N/A 
Day Low $10.35    EPS $ 
Volume 0